Effectiveness and Tolerability of Second-Line Therapy with Vildagliptin Versus Other Oral Agents in Type 2 Diabetes (EDGE): Post Hoc Sub-Analysis of Bulgarian Data

Abstract

OBJECTIVES Metformin is an established first-line treatment for type 2 diabetes mellitus (T2DM) patients but intensification of oral anti-diabetic therapy is usually required over time. The effectiveness of diabetes control with vildaGliptin and vildagliptin/mEtformin (EDGE) study compared effectiveness and safety of vildagliptin and other oral anti… (More)
DOI: 10.1007/s13300-014-0083-x

Topics

9 Figures and Tables

Cite this paper

@inproceedings{Kamenov2014EffectivenessAT, title={Effectiveness and Tolerability of Second-Line Therapy with Vildagliptin Versus Other Oral Agents in Type 2 Diabetes (EDGE): Post Hoc Sub-Analysis of Bulgarian Data}, author={Zdravko Asenov Kamenov}, booktitle={Diabetes therapy : research, treatment and education of diabetes and related disorders}, year={2014} }